First National Corp’s Halozyme HALO Stock Holding History

First National Corp’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,710	Closed	-$28K	–	251
2019 Q1	$28K	Hold	1,710	–	–	0.01%	254
2018 Q4	$25K	Buy	+1,710	New	+$27.3K	0.01%	262

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

First National Corp's HALO Position: Q2 2019 in Review

First National Corp sold out of Halozyme (HALO) in Q2 2019, closing a stake of 1,710 shares — an estimated $28K sold.

First National Corp first reported a position in HALO in Q4 2018 and held it in 2 quarters. The position peaked at $28K in Q1 2019. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

First National Corp reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
First National Corp sold 1,710 Halozyme shares in Q2 2019, an estimated $28K.
First National Corp first reported a position in Halozyme in Q4 2018 and held it in 2 quarters.
First National Corp's Halozyme position peaked at $28K in Q1 2019.
202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.